The Institute of Cancer Research aims to become a world-leading center in the field of scientific research and commercialization on oncology. Sticking to the core idea of people first and science foremost, our institute sets up a world-class oncological research and commercialization team combined with the numerous advantages of the Greater Bay Area of Guangdong, Hong Kong and Macao (for instance: strong IT and Big Data processing power, pluralistic technical entrepreneurial team, developed hospital network system and superior environment for scientific research). We attach importance to the introduction of scientists with a profound academic background and foresighted original research and have preliminarily established a research institute supported by new and cutting-edge technology. We concentrate our strength on making breakthroughs in key diseases and key scientific/technological issues, strive for further interdisciplinary integration and actively open our arm for cooperation with the hospitals, pharmaceutical companies and R&D institutions at home and abroad. We have achieved a batch of research results ranging from unicellular level to cohort. We also strive to lead the way in oncobiological basic theory and clinical research. In terms of the application of research findings and innovations in diagnosis and treatment of oncology we provide effective support for the major national or local scientific research projects in our country, making contributions to the advancement of “Healthy China”.